Scinai Immunotherapeutics Ltd. reported earnings of -$ 8.00 per SCNI share on Nov 5, 2026, falling short of analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 8.50 |
| Earnings Per Share (Surprise) | -$ 8.00 (+$ 0.50) |
| Last Year's EPS | -$ 12.12 |
| EPS YoY Change |
Out of the last 55 earnings reporting periods, Scinai Immunotherapeutics Ltd. beat analysts’ expectations 8 times and fell short of expectations 2 time(s). Scinai Immunotherapeutics Ltd. reported earnings per share of -$ 8.00 in the last report surpassing an estimated EPS of -$ 8.50 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 8.50 | -$ 8.00 | -$ 35.70 | |
| Aug 24, 2026 | - | -$ 0.74 | -$ 1.20 | |
| Jun 10, 2026 | - | $ 9.40 | $ 0.00 | |
| Dec 2, 2025 | - | -$ 13.32 | -$ 10.40 | |
| Nov 2, 2025 | - | -$ 35.70 | $ 8.40 | |
| Sep 2, 2025 | - | -$ 1.20 | -$ 3.57 | |
| May 30, 2025 | - | $ 0.00 | -$ 4.00 | |
| May 7, 2025 | - | -$ 10.40 | -$ 2,400.00 | |
| Nov 22, 2024 | - | $ 8.40 | -$ 6.60 | |
| Aug 15, 2024 | - | -$ 3.57 | -$ 11.10 | |
| Jul 2, 2024 | -$ 62.00 | -$ 4.00 | -$ 54.50 | |
| May 15, 2024 | -$ 6.20 | -$ 2,400.00 | -$ 3.00 | |
| Oct 31, 2023 | -$ 94.00 | -$ 6.60 | $ 0.2898 | |
| Aug 11, 2023 | -$ 9.10 | -$ 11.10 | $ 0.004 | |
| May 15, 2023 | -$ 220.00 | -$ 54.50 | -$ 6.12 | |
| Apr 17, 2023 | - | -$ 3.00 | -$ 0.01 | |
| Nov 30, 2022 | -$ 10.00 | $ 0.2898 | -$ 5.00 | |
| Sep 30, 2022 | -$ 10.00 | $ 0.004 | -$ 0.01 | |
| Aug 25, 2022 | -$ 10.00 | -$ 6.12 | $ 0.0066 | |
| Jun 30, 2022 | -$ 10.00 | -$ 0.01 | -$ 0.02 |
Scinai Immunotherapeutics Ltd.’s stock was trading at $ 0.4488 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, SCNI’s price decreased to $ 0.441 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 8.00 | $ 0.4488 | $ 0.441 | |
| Aug 24, 2026 | -$ 0.74 | $ 3.22 | $ 2.88 | |
| Jun 10, 2026 | $ 9.40 | $ 3.54 | $ 3.25 | |
| Dec 2, 2025 | -$ 13.32 | $ 10.00 | $ 11.50 | |
| Nov 2, 2025 | -$ 35.70 | $ 14.00 | $ 12.70 | |
| Sep 2, 2025 | -$ 1.20 | $ 15.30 | $ 16.10 | |
| May 30, 2025 | $ 0.00 | $ 26.90 | $ 25.00 | |
| May 7, 2025 | -$ 10.40 | $ 28.10 | $ 28.00 | |
| Nov 22, 2024 | $ 8.40 | $ 30.20 | $ 35.30 | |
| Aug 15, 2024 | -$ 3.57 | $ 37.00 | $ 38.80 | |
| Jul 2, 2024 | -$ 4.00 | $ 29.40 | $ 31.30 | |
| May 15, 2024 | -$ 2,400.00 | $ 44.00 | $ 45.00 | |
| Oct 31, 2023 | -$ 6.60 | $ 63.70 | $ 68.00 | |
| Aug 11, 2023 | -$ 11.10 | $ 132.00 | $ 130.00 | |
| May 15, 2023 | -$ 54.50 | $ 189.00 | $ 181.00 | |
| Apr 17, 2023 | -$ 3.00 | $ 179.00 | $ 195.00 | |
| Nov 30, 2022 | $ 0.2898 | $ 955.00 | $ 976.50 | |
| Sep 30, 2022 | $ 0.004 | $ 659.90 | $ 700.00 | |
| Aug 25, 2022 | -$ 6.12 | $ 1,160.00 | $ 1,140.00 | |
| Jun 30, 2022 | -$ 0.01 | $ 1,170.00 | $ 1,170.00 |
Scinai Immunotherapeutics Ltd. released its most recent earnings reports in November 2026, August 2026, June 2026, December 2025 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Scinai Immunotherapeutics Ltd. beat analysts’ expectations during the last earnings period by
